BackNeumora Therapeutics Overview

Neumora Therapeutics Total Assets

Neumora Therapeutics's total assets is $130M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$125.25M
↓ 44.04% YoYΔ $-98.58M vs prior year quarter

Peer trimmed avg / median

Loading

Neumora Therapeutics Total Assets History

Loading

Neumora Therapeutics vs. peers: Total Assets Comparison

Loading

Neumora Therapeutics Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Neumora Therapeutics (NMRA) FAQ

Neumora Therapeutics (NMRA) currently reports a total assets of $130M as of June 2026. That compares with $220M in the prior-year period — down 44.0% year over year. Use the charts on this page to explore Neumora Therapeutics's total assets history and peer comparisons.

Neumora Therapeutics's total assets decreased from $220M to $130M — a 44.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Neumora Therapeutics reported $130M in total assets as of June 2026. That compares with $220M in the prior-year period — down 44.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $130M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Neumora Therapeutics, and consider following NMRA for alerts when major investors trade the stock.